QUOTE AND NEWS
Forbes  10 hrs ago  Comment 
In trading on Monday, the Junior Gold Miners ETF (GDXJ) is outperforming other ETFs, up about 3.2% on the day.  Components of that ETF showing particular strength include shares of Coeur Mining (CDE), up about 8.8% and shares of Silver Standard...
Market Intelligence Center  Apr 15  Comment 
S&P Biotech SPDR (XBI) closed Tuesday at $231.90 and technical indicators recently have been bullish. Based in part on those numbers, MarketIntelligenceCenter.com's patented algorithms have identified a couple of attractive trading opportunities...
Forbes  Apr 13  Comment 
In trading on Monday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 1.8% on the day.  Components of that ETF showing particular strength include shares of Clovis Oncology (CLVS), up about 13.6% and shares of Incyte Genomics...
Forbes  Apr 1  Comment 
In trading on Wednesday, the Junior Gold Miners ETF (GDXJ) is outperforming other ETFs, up about 4.5% on the day.  Components of that ETF showing particular strength include shares of Bear Creek Mining (BCM.CA), up about 15.4% and shares of...
Forbes  Mar 26  Comment 
In trading on Thursday, the Gold Miners ETF (GDX) is outperforming other ETFs, up about 0.5% on the day.  Components of that ETF showing particular strength include shares of Harmony Gold Mining (HMY), up about 3.7% and shares of IAMGOLD (IAG),...
Forbes  Mar 25  Comment 
In trading on Wednesday, the Oil Services ETF (OIH) is outperforming other ETFs, up about 2.1% on the day.  Components of that ETF showing particular strength include shares of Transocean (RIG), up about 3.5% and shares of Ensco (ESV), up about...
Clusterstock  Mar 23  Comment 
Biogen shares spiked by more than 9% on Friday after it announced preliminary results for an Alzheimer's disease treatment called BIIB037. Stifel analysts had set a price target of $451 per share, and Biogen shot past that on Friday to as high...
Clusterstock  Mar 20  Comment 
Analysts are loving the latest news out of Biogen. On Friday, the company announced results on a test drug called aducanumab for Alzheimer's disease. Here's the key result, from the release: "Treatment with aducanumab produced a dose- and...
Forbes  Mar 19  Comment 
In trading on Thursday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 2.2% on the day.  Components of that ETF showing particular strength include shares of Amicus Therapeutics (FOLD), up about 36.7% and shares of Inovio...




RELATED WIKI ARTICLES
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki